Effective July 1, 2026, there will updates to the following InterQual Criteria subsets: 

    Durable Medical Equipment: 

• Prosthetics, Lower Extremity 

  CP: Procedures

• Tumor Treatment Field Therapy (TTFT)
• Arthroplasty of the Temporomandibular Joint (TMJ) 

    CP: Molecular Diagnostics 

• Hereditary Prostate Cancer
• HFE (Type I) Hereditary Hemochromatosis
• Hereditary Thrombophilia
• Niemann Pick Disease Type A and B
• Cystic Fibrosis and Cystic Fibrosis Transmembrane Regulator (CFTR) Disorders
• Beta Globin (HBB)
• Fragile X

If you would like a copy of the new version, please reach out to ProviderRelations@bcbsri.org.